At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 32 enrolled
Drug / intervention
Ferric maltol capsule +1 moredrug
Likely dose
Ferric maltol capsule 30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Open-Label, Single Dose, Four-Way Crossover, Phase I Study to Compare the Pharmacokinetics of Ferric Maltol Capsules and Oral Suspension Under Fasted and Fed Conditions in Adult Healthy Volunteers
In Brief
A Phase 1 clinical trial evaluating Ferric maltol capsule and Ferric maltol suspension for Anemia, Iron Deficiency. Completed, enrolled 32 participants across 1 site.
Detailed Summary
The purpose of the study is to compare the Pharmacokinetics (PK) of the new ferric maltol suspension, in adults, with the existing ferric maltol capsule.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia, Iron Deficiency
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
202120222023202420252026
Enrollment StartSep 2020
First PostedNov 2020
Primary CompletionNov 2020
TodayJul 2026
First PostedNov 12, 2020
Enrollment StartSep 28, 2020
Primary CompletionNov 13, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.6 years ago
Interventions
Ferric maltol capsuledrug
single dose of 30 mg capsule
Ferric maltol suspensiondrug
single dose of 30mg (5ml) oral suspension